SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-062890
Filing Date
2023-11-13
Accepted
2023-11-13 16:00:30
Documents
73
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q isco-20230930.htm   iXBRL 10-Q 2373731
2 EX-31.1 isco-ex31_1.htm EX-31.1 13512
3 EX-31.2 isco-ex31_2.htm EX-31.2 13422
4 EX-32.1 isco-ex32_1.htm EX-32.1 8502
5 EX-32.2 isco-ex32_2.htm EX-32.2 9079
  Complete submission text file 0000950170-23-062890.txt   10559881

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT isco-20230930_cal.xml EX-101.CAL 49195
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT isco-20230930_pre.xml EX-101.PRE 319731
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT isco-20230930_def.xml EX-101.DEF 193103
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT isco-20230930.xsd EX-101.SCH 56694
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT isco-20230930_lab.xml EX-101.LAB 413582
67 EXTRACTED XBRL INSTANCE DOCUMENT isco-20230930_htm.xml XML 2590114
Mailing Address 5950 PRIESTLY DRIVE CARLSBAD CA 92008
Business Address 5950 PRIESTLY DRIVE CARLSBAD CA 92008 760-940-6383
International Stem Cell CORP (Filer) CIK: 0001355790 (see all company filings)

IRS No.: 204494098 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-51891 | Film No.: 231398382
SIC: 2834 Pharmaceutical Preparations